What happened
For years the muscle question hung over GLP-1 drugs: a meaningful share of the weight people lose is not fat but lean mass, muscle and the tissue that holds you up. At the American Diabetes Association meeting, researchers showed one of the first serious attempts to fix it in a drug.
In the BELIEVE trial, bimagrumab (an experimental drug that builds muscle) was combined with semaglutide. The combination reached about 22% weight loss, and crucially, 92% of that loss came from fat. Lean-mass loss was held to under 3%, compared with 7.4% on semaglutide alone. People lost more total weight and kept more muscle.
Why this is the important number
This is the clearest sign yet that the field has accepted what the muscle research has said all along: how much you lose matters less than what kind of weight you lose. A scale that drops by taking muscle leaves you smaller but weaker, with a slower metabolism and a higher chance of regaining fat later.
The fact that drugmakers are now building medicines specifically to protect lean mass is, in a way, the strongest possible endorsement of treating muscle as the real outcome. It is no longer a niche concern. It is the next frontier.
The part you do not have to wait for
Here is what often gets lost: bimagrumab is years from your pharmacy, but the result it produces is something you can already protect yourself, today, on the drug you are on now.
The two proven tools cost nothing and work: enough protein (around 120g a day) and two short resistance-training sessions a week. In the research, together they cut muscle loss by 50 to 95%. That is not far off what an experimental muscle drug achieved. The women who do best on the next generation of these medicines are the ones already protecting their muscle on this one. (See why muscle is the number that matters.)
What it means for you
Read this as validation, not as something to wait for. The single idea behind this expensive new drug, lose fat without losing muscle, is the idea you can act on this week with protein and strength work.
What Steady does with this
This study is, almost word for word, the thesis Steady was built on.
- A protein target set to your goal weight, on the home screen, logged in seconds.
- Strength sessions tracked in a weekly scorecard, so the habit that protects muscle becomes a number you can see.
- Your weight read as a trend, not a single daily figure, so you stop trusting the one measurement that cannot tell muscle from fat.
The industry is spending billions to protect the thing Steady already helps you protect for free: what you keep.
